Dogged by setbacks and an air of crisis, Alexion Pharma opts to restructure, slashing staff
Not much has been going right for Alexion Pharma $ALXN over the past few months. Its CEO and CFO left under a cloud during …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
